Global Information
회사소개 | 문의

세계의 바이오시밀러 단클론항체 시장 분석과 예측(2018년)

Global Biosimilar Monoclonal Antibodies Sales Market Report 2018

리서치사 QYResearch
발행일 2018년 07월 상품 코드 668788
페이지 정보 영문 170 Pages
가격
US $ 4,000 ₩ 4,592,000 PDF by E-mail (Single User License)
US $ 8,000 ₩ 9,184,000 PDF by E-mail (Enterprise Wide License)


세계의 바이오시밀러 단클론항체 시장 분석과 예측(2018년) Global Biosimilar Monoclonal Antibodies Sales Market Report 2018
발행일 : 2018년 07월 페이지 정보 : 영문 170 Pages

한글목차

세계의 바이오시밀러 단클론항체 시장은 평균 32.6%의 성장률로 급성장을 이루고 있으며, 2017년 매출은 약 15억 달러, 제조 수량은 약 405만개로 추정되고 있습니다.

세계의 바이오시밀러 단클론항체(Biosimilar Monoclonal Antibodies) 시장을 조사했으며, 시장 및 제품 개요, 판매량·매출·가격 추이와 예측, 종류·용도·지역별 분석, 시장 성장 영향요인, 제조 및 판매 동향, 경쟁 환경과 시장 점유율, 주요 제조업체 개요 등의 정보를 정리하여 전해드립니다.

제1장 시장 개요

  • 제품 개요 및 조사 범위
  • 세계 시장 추이 및 전망 : 종류별
    • 매출 비교 : 종류별
    • 매출 점유율 : 종류별
    • 인플릭시맙(Infliximab)
    • 리툭시맙(Rituximab)
    • 트라스트주맙(Trastuzumab)
    • 아달리무맙(Adalimumab)
  • 세계 시장 추이 및 전망 : 용도/최종사용자별
    • 판매량 비교 : 용도별
    • 판매량 점유율 : 용도별
  • 세계 시장 추이 및 전망 : 지역별
  • 세계 매출·판매량 예측

제2장 경쟁 분석 : 기업·종류·용도별

  • 판매량·매출 추이 : 기업별
  • 판매량·매출 추이 : 종류별
  • 판매량·매출 추이 : 지역별
  • 판매량 추이 : 용도별

제3장 미국 시장 추이 : 판매량·매출·가격

  • 판매량·매출·가격 추이
  • 판매량·시장 점유율 추이 : 기업별
  • 판매량·시장 점유율 추이 : 종류별
  • 판매량·시장 점유율 추이 : 용도별

제4장 중국 시장 추이 : 판매량·매출·가격

  • 판매량·매출·가격 추이
  • 판매량·시장 점유율 추이 : 기업별
  • 판매량·시장 점유율 추이 : 종류별
  • 판매량·시장 점유율 추이 : 용도별

제5장 유럽 시장 추이 : 판매량·매출·가격

  • 판매량·매출·가격 추이
  • 판매량·시장 점유율 추이 : 기업별
  • 판매량·시장 점유율 추이 : 종류별
  • 판매량·시장 점유율 추이 : 용도별

제6장 한국 시장 추이 : 판매량·매출·가격

  • 판매량·매출·가격 추이
  • 판매량·시장 점유율 추이 : 기업별
  • 판매량·시장 점유율 추이 : 종류별
  • 판매량·시장 점유율 추이 : 용도별

제7장 인도 시장 추이 : 판매량·매출·가격

  • 판매량·매출·가격 추이
  • 판매량·시장 점유율 추이 : 기업별
  • 판매량·시장 점유율 추이 : 종류별
  • 판매량·시장 점유율 추이 : 용도별

제8장 기타 지역 시장 추이 : 판매량·매출·가격

  • 판매량·매출·가격 추이
  • 판매량·시장 점유율 추이 : 기업별
  • 판매량·시장 점유율 추이 : 종류별
  • 판매량·시장 점유율 추이 : 용도별

제9장 주요 기업 개요 및 판매 데이터

  • Celltrion
  • Pfizer(Hospira)
  • 3SBIO
  • Novartis(Sandoz)
  • Dr Reddy's
  • Celgen Biopharma
  • Cadila Healthcare
  • Hisun Pharma
  • Torrent Pharmaceuticals

제10장 제조 비용 분석

  • 원재료 분석
  • 제조 원가 구조

제11장 산업 체인·조달 전략·다운스트림(Downstream) 바이어

제12장 마케팅 전략 분석 및 유통업체/무역업체

  • 마케팅 경로
  • 시장 포지셔닝
  • 유통업체/무역업체 리스트

제13장 시장 영향요인 분석

  • 대체품의 위협
  • 소비자 요구/고객 취향 변화
  • 정치/경제 환경 변화

제14장 시장 예측

  • 판매량·매출·가격 예측
  • 판매량·매출·성장률 예측 : 지역별
  • 판매량·매출·가격 예측 : 종류별
  • 판매량 예측 : 용도별

제15장 조사 결과 및 결론

제16장 조사 방법 및 데이터 출처

LSH 18.08.07

List of Tables and Figures

  • Figure Product Picture of Biosimilar Monoclonal Antibodies
  • Table Global Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate Comparison by Types (2013-2025)
  • Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Types in 2017
  • Figure Infliximab Product Picture
  • Figure Rituximab Product Picture
  • Figure Trastuzumab Product Picture
  • Figure Adalimumab Product Picture
  • Table Global Biosimilar Monoclonal Antibodies Sales (K Unit) Comparison by Applications (2013-2025)
  • Figure Global Sales Market Share of Biosimilar Monoclonal Antibodies by Applications in 2017
  • Table Global Market Biosimilar Monoclonal Antibodies Revenue (M USD) Comparison by Regions 2013-2025
  • Figure United States Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2025)
  • Figure China Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2025)
  • Figure Europe Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2025)
  • Figure South Korea Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2025)
  • Figure Row Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2025)
  • Figure India Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2025)
  • Figure Global Biosimilar Monoclonal Antibodies Sales (K Unit) and Growth Rate (2013-2025)
  • Figure Global Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2025)
  • Table Global Biosimilar Monoclonal Antibodies Sales (K Unit) of Key Players (2017-2018)
  • Table Global Biosimilar Monoclonal Antibodies Sales Share by Players (2017-2018)
  • Figure 2017 Global Biosimilar Monoclonal Antibodies Sales Share by Players
  • Figure 2018 Global Biosimilar Monoclonal Antibodies Sales Share by Players
  • Table Global Biosimilar Monoclonal Antibodies Revenue (M USD) by Players (2017-2018)
  • Table Global Biosimilar Monoclonal Antibodies Revenue Share by Players (2017-2018)
  • Figure 2017 Global Biosimilar Monoclonal Antibodies Revenue Share by Players
  • Figure 2018 Global Biosimilar Monoclonal Antibodies Revenue Share by Players
  • Table Global Biosimilar Monoclonal Antibodies Sales (K Unit) by Type (2013-2018)
  • Table Global Biosimilar Monoclonal Antibodies Sales Share by Type (2013-2018)
  • Figure Sales Market Share of Biosimilar Monoclonal Antibodies by Type (2013-2018)
  • Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2017
  • Table Global Biosimilar Monoclonal Antibodies Revenue (M USD) and Market Share by Type (2013-2018)
  • Table Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2013-2018)
  • Figure Revenue Market Share of Biosimilar Monoclonal Antibodies by Type (2013-2018)
  • Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type in 2018
  • Table Global Biosimilar Monoclonal Antibodies Sales (K Unit) and Market Share by Regions (2013-2018)
  • Table Global Biosimilar Monoclonal Antibodies Sales Share by Regions (2013-2018)
  • Figure Sales Market Share of Biosimilar Monoclonal Antibodies by Regions (2013-2018)
  • Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Regions in 2017
  • Table Global Biosimilar Monoclonal Antibodies Revenue (M USD) and Market Share by Regions (2013-2018)
  • Table Global Biosimilar Monoclonal Antibodies Revenue Share by Regions (2013-2018)
  • Figure Revenue Market Share of Biosimilar Monoclonal Antibodies by Regions (2013-2018)
  • Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Regions in 2017
  • Table Global Biosimilar Monoclonal Antibodies Sales (K Unit) and Market Share by Application (2013-2018)
  • Table Global Biosimilar Monoclonal Antibodies Sales Share by Application (2013-2018)
  • Figure Sales Market Share of Biosimilar Monoclonal Antibodies by Application (2013-2018)
  • Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2017
  • Figure United States Biosimilar Monoclonal Antibodies Sales (K Unit) and Growth Rate (2013-2018)
  • Figure United States Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2018)
  • Figure United States Biosimilar Monoclonal Antibodies Price (USD/Unit) Trend (2013-2018)
  • Table United States Biosimilar Monoclonal Antibodies Sales (K Unit) by Players (2017-2018)
  • Table United States Biosimilar Monoclonal Antibodies Sales Market Share by Players (2017-2018)
  • Figure United States Biosimilar Monoclonal Antibodies Sales Market Share by Players in 2017
  • Table United States Biosimilar Monoclonal Antibodies Sales (K Unit) by Type (2013-2018)
  • Table United States Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
  • Figure United States Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2017
  • Table United States Biosimilar Monoclonal Antibodies Sales (K Unit) by Applications (2013-2018)
  • Table United States Biosimilar Monoclonal Antibodies Sales Market Share by Applications (2013-2018)
  • Figure United States Biosimilar Monoclonal Antibodies Sales Market Share by Applications in 2017
  • Figure China Biosimilar Monoclonal Antibodies Sales (K Unit) and Growth Rate (2013-2018)
  • Figure China Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2018)
  • Figure China Biosimilar Monoclonal Antibodies Price (USD/Unit) Trend (2013-2018)
  • Table China Biosimilar Monoclonal Antibodies Sales (K Unit) by Players (2017-2018)
  • Table China Biosimilar Monoclonal Antibodies Sales Market Share by Players (2017-2018)
  • Figure China Biosimilar Monoclonal Antibodies Sales Market Share by Players in 2017
  • Table China Biosimilar Monoclonal Antibodies Sales (K Unit) by Type (2013-2018)
  • Table China Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
  • Figure China Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2017
  • Table China Biosimilar Monoclonal Antibodies Sales (K Unit) by Applications (2013-2018)
  • Table China Biosimilar Monoclonal Antibodies Sales Market Share by Applications (2013-2018)
  • Figure China Biosimilar Monoclonal Antibodies Sales Market Share by Applications in 2017
  • Figure Europe Biosimilar Monoclonal Antibodies Sales (K Unit) and Growth Rate (2013-2018)
  • Figure Europe Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2018)
  • Figure Europe Biosimilar Monoclonal Antibodies Price (USD/Unit) Trend (2013-2018)
  • Table Europe Biosimilar Monoclonal Antibodies Sales (K Unit) by Players (2017-2018)
  • Table Europe Biosimilar Monoclonal Antibodies Sales Market Share by Players (2017-2018)
  • Figure Europe Biosimilar Monoclonal Antibodies Sales Market Share by Players in 2017
  • Table Europe Biosimilar Monoclonal Antibodies Sales (K Unit) by Type (2013-2018)
  • Table Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
  • Figure Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2017
  • Table Europe Biosimilar Monoclonal Antibodies Sales (K Unit) by Applications (2013-2018)
  • Table Europe Biosimilar Monoclonal Antibodies Sales Market Share by Applications (2013-2018)
  • Figure Europe Biosimilar Monoclonal Antibodies Sales Market Share by Applications in 2017
  • Figure South Korea Biosimilar Monoclonal Antibodies Sales (K Unit) and Growth Rate (2013-2018)
  • Figure South Korea Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2018)
  • Figure South Korea Biosimilar Monoclonal Antibodies Price (USD/Unit) Trend (2013-2018)
  • Table South Korea Biosimilar Monoclonal Antibodies Sales (K Unit) by Players (2017-2018)
  • Table South Korea Biosimilar Monoclonal Antibodies Sales Market Share by Players (2017-2018)
  • Figure South Korea Biosimilar Monoclonal Antibodies Sales Market Share by Players in 2017
  • Table South Korea Biosimilar Monoclonal Antibodies Sales (K Unit) by Type (2013-2018)
  • Table South Korea Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
  • Figure South Korea Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2017
  • Table South Korea Biosimilar Monoclonal Antibodies Sales (K Unit) by Applications (2013-2018)
  • Table South Korea Biosimilar Monoclonal Antibodies Sales Market Share by Applications (2013-2018)
  • Figure South Korea Biosimilar Monoclonal Antibodies Sales Market Share by Applications in 2017
  • Figure India Biosimilar Monoclonal Antibodies Sales (K Unit) and Growth Rate (2013-2018)
  • Figure India Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2018)
  • Figure India Biosimilar Monoclonal Antibodies Price (USD/Unit) Trend (2013-2018)
  • Table India Biosimilar Monoclonal Antibodies Sales (K Unit) by Players (2017-2018)
  • Table India Biosimilar Monoclonal Antibodies Sales Market Share by Players (2017-2018)
  • Figure India Biosimilar Monoclonal Antibodies Sales Market Share by Players in 2017
  • Table India Biosimilar Monoclonal Antibodies Sales (K Unit) by Type (2013-2018)
  • Table India Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
  • Figure India Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2017
  • Table India Biosimilar Monoclonal Antibodies Sales (K Unit) by Applications (2013-2018)
  • Table India Biosimilar Monoclonal Antibodies Sales Market Share by Applications (2013-2018)
  • Figure India Biosimilar Monoclonal Antibodies Sales Market Share by Applications in 2017
  • Figure Row Biosimilar Monoclonal Antibodies Sales (K Unit) and Growth Rate (2013-2018)
  • Figure Row Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate (2013-2018)
  • Figure Row Biosimilar Monoclonal Antibodies Price (USD/Unit) Trend (2013-2018)
  • Table Row Biosimilar Monoclonal Antibodies Sales (K Unit) by Players (2017-2018)
  • Table Row Biosimilar Monoclonal Antibodies Sales Market Share by Players (2017-2018)
  • Figure Row Biosimilar Monoclonal Antibodies Sales Market Share by Players in 2017
  • Table Row Biosimilar Monoclonal Antibodies Sales (K Unit) by Type (2013-2018)
  • Table Row Biosimilar Monoclonal Antibodies Sales Market Share by Type (2013-2018)
  • Figure Row Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2017
  • Table Row Biosimilar Monoclonal Antibodies Sales (K Unit) by Applications (2013-2018)
  • Table Row Biosimilar Monoclonal Antibodies Sales Market Share by Applications (2013-2018)
  • Figure Row Biosimilar Monoclonal Antibodies Sales Market Share by Applications in 2017
  • Table Celltrion Company Profile
  • Figure Biosimilar Monoclonal Antibodies Product Picture of Celltrion
  • Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Celltrion 2017-2018
  • Table Pfizer (Hospira) Company Profile
  • Figure Biosimilar Monoclonal Antibodies Product Picture of Pfizer (Hospira)
  • Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer (Hospira) 2017-2018
  • Table 3SBIO Company Profile
  • Figure Biosimilar Monoclonal Antibodies Product Picture of 3SBIO
  • Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of 3SBIO 2017-2018
  • Table Novartis (Sandoz) Company Profile
  • Figure Biosimilar Monoclonal Antibodies Product Picture of Novartis (Sandoz)
  • Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novartis (Sandoz) 2017-2018
  • Table Dr Reddy's Company Profile
  • Figure Biosimilar Monoclonal Antibodies Product Picture of Dr Reddy's
  • Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Dr Reddy's 2017-2018
  • Table Celgen Biopharma Company Profile
  • Figure Biosimilar Monoclonal Antibodies Product Picture of Celgen Biopharma
  • Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Celgen Biopharma 2017-2018
  • Table Cadila Healthcare Company Profile
  • Figure Biosimilar Monoclonal Antibodies Product Picture of Cadila Healthcare
  • Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Cadila Healthcare 2017-2018
  • Table Hisun Pharma Company Profile
  • Figure Biosimilar Monoclonal Antibodies Product Picture of Hisun Pharma
  • Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Hisun Pharma 2017-2018
  • Table Torrent Pharmaceuticals Company Profile
  • Figure Biosimilar Monoclonal Antibodies Product Picture of Torrent Pharmaceuticals
  • Table Biosimilar Monoclonal Antibodies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Torrent Pharmaceuticals 2017-2018
  • Table Out-of-pocket Preclinical and Clinical Period Cost Per Investigational Biopharmaceutical Compound
  • Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
  • Figure Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
  • Figure USA Labor Cost Analysis 2015-2018
  • Figure Cost of Employing a Factory Worker
  • Figure Europe Labor Cost Analysis 2015-2018
  • Figure Germany Labor Cost Analysis 2015-2018
  • Figure UK Labor Cost Analysis 2015-2018
  • Figure France Labor Cost Analysis 2015-2018
  • Figure Italy Labor Cost Analysis 2015-2018
  • Figure Monthly Minimum Wages in Asia 2016
  • Figure China Labor Costs 2015-2018
  • Figure Japan Average Monthly Wages 2015-2018
  • Table Average Price of Electricity to Ultimate Customers 2007-2016
  • Figure Electricity Prices for Household Consumers in 2016
  • Figure Summary of the Driving Assumptions
  • Figure Industrial Electric Rates 2016 (PER KWH)
  • Figure Biosimilar Monoclonal Antibodies Industrial Chain Analysis
  • Table Major Buyers of Biosimilar Monoclonal Antibodies
  • Figure Marketing Channel for Biopharmaceuticals
  • Figure Conceptual Model of the Flow of Products, Services and Funds for Non-specialty Drugs Coveredunder Private Insurance and Purchased in a Retail Setting
  • Figure Marketing Channel for Biopharmaceuticals
  • Figure Flow of US Prescription Sales Contribution by Channel
  • Figure Market Channel of Biosimilar Monoclonal Antibodies
  • Figure Setting Pricing Policy
  • Table Distributors/Traders List
  • Table Major Monoclonal Antibodies Informtion Analisis

Top 20 Countries Highest Incidence of Colorectal Cancer in 2016 119

Top 20 Countries Highest Incidence of Lung Cancer in 2016 120

Top 20 Countries Highest Incidence of Pancreatic Cancer in 2016 120

Top 20 Countries Highest Incidence of Breast Cancer in 2016 121

  • Figure Global GDP Growth Rate for 2016
  • Figure Real GDP Growth 2016-2020 annual Average
  • Figure USA GDP 2008-2016 (Billion USD)
  • Figure USA GDP Growth Rate Change 2015-2018
  • Figure EU GDP 2008-2016 (Billion USD)
  • Figure EU GDP Growth Rate Change 2015-2018
  • Figure Germany GDP 2008-2016 (Billion USD)
  • Figure Germany GDP Growth Rate 2015-2018
  • Figure UK GDP 2008-2016 (Billion USD)
  • Figure UK GDP Growth Rate 2015-2018
  • Figure Italy GDP 2008-2016 (Billion USD)
  • Figure Italy GDP Growth Rate 2015-2018
  • Figure France GDP 2008-2016 (Billion USD)
  • Figure France GDP Growth Rate 2015-2018
  • Figure Japan GDP 2008-2016 (Billion USD)
  • Figure Japan GDP Growth Rate 2015-2018
  • Figure China GDP 2008-2016 (Billion USD)
  • Figure China GDP Growth Rate 2015-2018
  • Figure Global Biosimilar Monoclonal Antibodies Sales (K Unit) and Growth Rate Forecast (2019-2025)
  • Figure Global Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate Forecast (2019-2025)
  • Figure Global Biosimilar Monoclonal Antibodies Price (USD/Unit) and Trend Forecast (2019-2025)
  • Table Global Biosimilar Monoclonal Antibodies Sales (K Unit) Forecast by Regions (2019-2025)
  • Figure Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Regions (2019-2025)
  • Figure Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Regions in 2025
  • Table Global Biosimilar Monoclonal Antibodies Revenue (M USD) Forecast by Regions (2019-2025)
  • Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Regions (2019-2025)
  • Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Regions in 2025
  • Figure United States Biosimilar Monoclonal Antibodies Sales (K Unit) and Growth Rate Forecast (2019-2025)
  • Figure United States Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate Forecast (2019-2025)
  • Figure Europe Biosimilar Monoclonal Antibodies Sales (K Unit) and Growth Rate Forecast (2019-2025)
  • Figure Europe Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate Forecast (2019-2025)
  • Figure China Biosimilar Monoclonal Antibodies Sales (K Unit) and Growth Rate Forecast (2019-2025)
  • Figure China Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate Forecast (2019-2025)
  • Figure South Korea Biosimilar Monoclonal Antibodies Sales (K Unit) and Growth Rate Forecast (2019-2025)
  • Figure South Korea Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate Forecast (2019-2025)
  • Figure Row Biosimilar Monoclonal Antibodies Sales (K Unit) and Growth Rate Forecast (2019-2025)
  • Figure Row Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate Forecast (2019-2025)
  • Figure India Biosimilar Monoclonal Antibodies Sales (K Unit) and Growth Rate Forecast (2019-2025)
  • Figure India Biosimilar Monoclonal Antibodies Revenue (M USD) and Growth Rate Forecast (2019-2025)
  • Table Global Biosimilar Monoclonal Antibodies Sales (K Unit) Forecast by Type (2019-2025)
  • Figure Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Type (2019-2025)
  • Table Global Biosimilar Monoclonal Antibodies Revenue (M USD) Forecast by Type (2019-2025)
  • Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Type (2019-2025)
  • Table Global Biosimilar Monoclonal Antibodies Sales (K Unit) Forecast by Application (2019-2025)
  • Figure Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Application (2019-2025)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources

영문목차

This report studies the Biosimilar Monoclonal Antibodies market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Biosimilar Monoclonal Antibodies market by product type and applications.

In the last several years, global market of Biosimilar Monoclonal Antibodies developed rapidly, with an average growth rate of 32.6%. In 2017, global revenue of Biosimilar Monoclonal Antibodies is nearly 1500 M USD; the actual production is about 4.05 M Units.

Patent expirations on essential biological drugs is expected to create wider scope for potential opportunities for key players in the biosimilar monoclonal antibodies market in the near future.

However, lack of appropriate standards, stringent government regulations in developed countries, and high research and development costs for development of biosimilar monoclonal antibodies are some major factors restraining growth of the global biosimilar monoclonal antibodies market.

The major players in global Biosimilar Monoclonal Antibodies market include:

  • Celltrion
  • Pfizer (Hospira)
  • 3SBIO
  • Novartis (Sandoz)
  • Dr Reddy's
  • Celgen Biopharma
  • Cadila Healthcare
  • Hisun Pharma
  • Torrent Pharmaceuticals

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Biosimilar Monoclonal Antibodies in these regions, from 2013 to 2025 (forecast), covering:

  • North America
  • Europe
  • China
  • South Korea
  • India
  • Rest of World

On the basis of product, the Biosimilar Monoclonal Antibodies market is primarily split into:

  • Infliximab
  • Rituximab
  • Trastuzumab
  • Adalimumab
  • Other

On the basis on the end users/applications, this report covers:

  • Oncology
  • Autoimmune Disease
  • Other

Table of Contents

1. Biosimilar Monoclonal Antibodies Market Overview

  • 1.1. Product Overview and Scope of Biosimilar Monoclonal Antibodies
  • 1.2. Classification of Biosimilar Monoclonal Antibodies by Product Category
    • 1.2.1. Global Biosimilar Monoclonal Antibodies Revenue and Growth Comparison by Types (2013-2025)
    • 1.2.2. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Types in 2017
    • 1.2.3. Infliximab
    • 1.2.4. Rituximab
    • 1.2.5. Trastuzumab
    • 1.2.6. Adalimumab
  • 1.3. Global Biosimilar Monoclonal Antibodies Market by Applications/End Users
    • 1.3.1. Global Biosimilar Monoclonal Antibodies Sales Comparison by Applications (2013-2025)
    • 1.3.2. Global Biosimilar Monoclonal Antibodies Sales Market Share by Applications
  • 1.4. Global Biosimilar Monoclonal Antibodies Market by Regions
    • 1.4.1. Global Biosimilar Monoclonal Antibodies Revenue Comparison by Regions (2013-2025)
    • 1.4.2. United States Biosimilar Monoclonal Antibodies Status and Prospect (2013-2025)
    • 1.4.3. China Biosimilar Monoclonal Antibodies Status and Prospect (2013-2025)
    • 1.4.4. Europe Biosimilar Monoclonal Antibodies Status and Prospect (2013-2025)
    • 1.4.5. South Korea Biosimilar Monoclonal Antibodies Status and Prospect (2013-2025)
    • 1.4.6. Row Biosimilar Monoclonal Antibodies Status and Prospect (2013-2025)
    • 1.4.7. India Biosimilar Monoclonal Antibodies Status and Prospect (2013-2025)
  • 1.5. Global Biosimilar Monoclonal Antibodies Sales and Revenue (2013-2025)
    • 1.5.1. Global Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2025)
    • 1.5.2. Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2025)

2. Global Biosimilar Monoclonal Antibodies Competition by Players, Type and Application

  • 2.1. Global Biosimilar Monoclonal Antibodies Market Competition by Players
    • 2.1.1. Global Biosimilar Monoclonal Antibodies Sales and Market Share of Key Players (2017-2018)
    • 2.1.2. Global Biosimilar Monoclonal Antibodies Revenue and Share by Players (2017-2018)
  • 2.2. Global Biosimilar Monoclonal Antibodies Sales and Revenue by Type
    • 2.2.1. Global Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2013-2018)
    • 2.2.2. Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2013-2018)
  • 2.3. Global Biosimilar Monoclonal Antibodies Sales and Revenue by Regions
    • 2.3.1. Global Biosimilar Monoclonal Antibodies Sales and Market Share by Regions (2013-2018)
    • 2.3.2. Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Regions (2013-2018)
  • 2.4. Global Biosimilar Monoclonal Antibodies Sales by Application

3. United States Biosimilar Monoclonal Antibodies (Sales, Revenue and Price)

  • 3.1. United States Biosimilar Monoclonal Antibodies Sales and Revenue (2013-2018)
    • 3.1.1. United States Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    • 3.1.2. United States Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
    • 3.1.3. United States Biosimilar Monoclonal Antibodies Price Trend (2013-2018)
  • 3.2. United States Biosimilar Monoclonal Antibodies Sales and Market Share by Players
  • 3.3. United States Biosimilar Monoclonal Antibodies Sales and Market Share by Type
  • 3.4. United States Biosimilar Monoclonal Antibodies Sales and Market Share by Applications

4. China Biosimilar Monoclonal Antibodies (Sales, Revenue and Price)

  • 4.1. China Biosimilar Monoclonal Antibodies Sales and Revenue (2013-2018)
    • 4.1.1. China Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    • 4.1.2. China Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
    • 4.1.3. China Biosimilar Monoclonal Antibodies Price Trend (2013-2018)
  • 4.2. China Biosimilar Monoclonal Antibodies Sales and Market Share by Players
  • 4.3. China Biosimilar Monoclonal Antibodies Sales and Market Share by Type
  • 4.4. China Biosimilar Monoclonal Antibodies Sales and Market Share by Applications

5. Europe Biosimilar Monoclonal Antibodies (Sales, Revenue and Price)

  • 5.1. Europe Biosimilar Monoclonal Antibodies Sales and Value (2013-2018)
    • 5.1.1. Europe Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    • 5.1.2. Europe Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
    • 5.1.3. Europe Biosimilar Monoclonal Antibodies Price Trend (2013-2018)
  • 5.2. Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Players
  • 5.3. Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Type
  • 5.4. Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Applications

6. South Korea Biosimilar Monoclonal Antibodies (Sales, Revenue and Price)

  • 6.1. South Korea Biosimilar Monoclonal Antibodies Sales and Value (2013-2018)
    • 6.1.1. South Korea Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    • 6.1.2. South Korea Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
    • 6.1.3. South Korea Biosimilar Monoclonal Antibodies Price Trend (2013-2018)
  • 6.2. South Korea Biosimilar Monoclonal Antibodies Sales and Market Share by Players
  • 6.3. South Korea Biosimilar Monoclonal Antibodies Sales and Market Share by Type
  • 6.4. South Korea Biosimilar Monoclonal Antibodies Sales and Market Share by Applications

7. India Biosimilar Monoclonal Antibodies (Sales, Revenue and Price)

  • 7.1. India Biosimilar Monoclonal Antibodies Sales and Value (2013-2018)
    • 7.1.1. India Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    • 7.1.2. India Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
    • 7.1.3. India Biosimilar Monoclonal Antibodies Price Trend (2013-2018)
  • 7.2. India Biosimilar Monoclonal Antibodies Sales and Market Share by Players
  • 7.3. India Biosimilar Monoclonal Antibodies Sales and Market Share by Type
  • 7.4. India Biosimilar Monoclonal Antibodies Sales and Market Share by Applications

8. Row Biosimilar Monoclonal Antibodies (Sales, Revenue and Price)

  • 8.1. Row Biosimilar Monoclonal Antibodies Sales and Value (2013-2018)
    • 8.1.1. Row Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
    • 8.1.2. Row Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2013-2018)
    • 8.1.3. Row Biosimilar Monoclonal Antibodies Price Trend (2013-2018)
  • 8.2. Row Biosimilar Monoclonal Antibodies Sales and Market Share by Players
  • 8.3. Row Biosimilar Monoclonal Antibodies Sales and Market Share by Type
  • 8.4. Row Biosimilar Monoclonal Antibodies Sales and Market Share by Applications

9. Analysis of Biosimilar Monoclonal Antibodies Industry Key Manufacturers

  • 9.1. Celltrion
    • 9.1.1. Company Profile
    • 9.1.2. Product Information
    • 9.1.3. Sales, Price, Cost, Gross, and Revenue
  • 9.2. Pfizer (Hospira)
    • 9.2.1. Company Profile
    • 9.2.2. Product Information
    • 9.2.3. Sales, Price, Cost, Gross, and Revenue
  • 9.3. 3SBIO
    • 9.3.1. Company Profile
    • 9.3.2. Product Information
    • 9.3.3. Sales, Price, Cost, Gross, and Revenue
  • 9.4. Novartis (Sandoz)
    • 9.4.1. Company Profile
    • 9.4.2. Product Information
    • 9.4.3. Sales, Price, Cost, Gross, and Revenue
  • 9.5. Dr Reddy's
    • 9.5.1. Company Profile
    • 9.5.2. Product Information
    • 9.5.3. Sales, Price, Cost, Gross, and Revenue
  • 9.6. Celgen Biopharma
    • 9.6.1. Company Profile
    • 9.6.2. Product Information
    • 9.6.3. Sales, Price, Cost, Gross, and Revenue
  • 9.7. Cadila Healthcare
    • 9.7.1. Company Profile
    • 9.7.2. Product Information
    • 9.7.3. Sales, Price, Cost, Gross, and Revenue
  • 9.8. Hisun Pharma
    • 9.8.1. Company Profile
    • 9.8.2. Product Information
    • 9.8.3. Sales, Price, Cost, Gross, and Revenue
  • 9.9. Torrent Pharmaceuticals
    • 9.9.1. Company Profile
    • 9.9.2. Product Information
    • 9.9.3. Sales, Price, Cost, Gross, and Revenue

10. Biosimilar Monoclonal Antibodies Manufacturing Cost Analysis

  • 10.1. Biosimilar Monoclonal Antibodies Key Raw Materials Analysis
    • 10.1.1. Clinical Phase Costs
    • 10.1.2. Capitalized Costs
  • 10.2. Proportion of Manufacturing Cost Structure
    • 10.2.1. Raw Materials
    • 10.2.2. Labor Cost
    • 10.2.3. Other Costs Analysis

11. Industrial Chain, Sourcing Strategy and Downstream Buyers

  • 11.1. Biosimilar Monoclonal Antibodies Industrial Chain Analysis
  • 11.2. Upstream Raw Materials Sourcing
  • 11.3. Downstream Buyers

12. Marketing Strategy Analysis, Distributors/Traders

  • 12.1. Marketing Channel
    • 12.1.1. Direct Marketing
    • 12.1.2. Indirect Marketing
    • 12.1.3. Marketing Channel Development Trend
  • 12.2. Market Positioning
    • 12.2.1. Pricing Strategy
    • 12.2.2. Brand Strategy
  • 12.3. Distributors/Traders List

13. Market Effect Factors Analysis

  • 13.1. Substitutes Threat
  • 13.2. Consumer Needs/Customer Preference Change
  • 13.3. Economic/Political Environmental Change

14. Global Biosimilar Monoclonal Antibodies Market Forecast (2019-2025)

  • 14.1. Global Biosimilar Monoclonal Antibodies Sales (K Unit), Revenue and Price Forecast (2019-2025)
    • 14.1.1. Global Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast (2019-2025)
    • 14.1.2. Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2019-2025)
    • 14.1.3. Global Biosimilar Monoclonal Antibodies Price and Trend Forecast (2019-2025)
  • 14.2. Global Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast by Regions (2019-2025)
    • 14.2.1. Global Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast by Regions (2019-2025)
    • 14.2.2. Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast by Regions (2019-2025)
    • 14.2.3. United States Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast (2019-2025)
    • 14.2.4. Europe Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast (2019-2025)
    • 14.2.5. China Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast (2019-2025)
    • 14.2.6. South Korea Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast (2019-2025)
    • 14.2.7. Row Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast (2019-2025)
    • 14.2.8. India Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate Forecast (2019-2025)
  • 14.3. Global Biosimilar Monoclonal Antibodies Sales, Revenue and Price Forecast by Type (2019-2025)
    • 14.3.1. Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2019-2025)
    • 14.3.2. Global Biosimilar Monoclonal Antibodies Revenue Forecast by Type (2019-2025)
  • 14.4. Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2019-2025)

15. Research Findings and Conclusion

16. Methodology and Data Source

  • 16.1. Methodology/Research Approach
    • 16.1.1. Research Programs/Design
    • 16.1.2. Market Size Estimation
    • 16.1.3. Market Breakdown and Data Triangulation
  • 16.2. Data Source
    • 16.2.1. Secondary Sources
    • 16.2.2. Primary Sources
  • 16.3. Disclaimer
  • 16.4. Author List
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research